Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Caprelsa 300 mg film coated tablets (PLGB04425/0762)

Active Ingredient:
vandetanib
Company:  
Sanofi Genzyme See contact details
ATC code: 
L01EX04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Caprelsa-Healthcare Professional (HCP) Guide - Risk Minimisation Information for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals

For hard copies, please contact medical information department at 0800 035 2525 or email [email protected].

{pdf_link}

Caprelsa-Patient Alert Card

For hard copies, please contact medical information department at 0800 035 2525 or email [email protected].

{pdf_link}

Caprelsa-Patient Guide - Risk Minimisation Information for Patients

{healthcare_pro_orange} For Healthcare Professionals

For hard copies, please contact medical information department at 0800 035 2525 or email [email protected].

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Sanofi Genzyme
Company image
Address
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Medical Information Direct Line
+44 (0)800 035 2525
Medical Information e-mail
[email protected]